Elanco

The latest read

Computed from the data on Oct 23, 2026. Every figure links back to its source in the sections below.

• Revenue over the four quarters to June 30, 2026: $5.02 billion, up 12% from a year earlier.SEC EDGAR filings (XBRL)
• Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $0.38 billion, up 5.6% from a year earlier.SEC EDGAR filings (XBRL)
• Capital expenditure over the four quarters to June 30, 2026: $0.24 billion, up 14% from a year earlier.SEC EDGAR filings (XBRL)
• Long-term debt issued in the fiscal year to December 31, 2025: $2.11 billion.SEC EDGAR filings (10-K)
• Latest earnings call or results release (August 5, 2026): sentiment 0.80 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.90 of 1.Palanor Discourse
• Guidance in the last 90 days: 3 outlook figures raised, 1 lowered, 0 held.Guidance Ledger (8-K results releases)
• Latest annual report (filed February 24, 2026): 0 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
• Insiders were net buyers in Q3 2026: $1.5 million on the open market.SEC Form 4
• 521 institutional managers reported a position at June 30, 2026 (+3 on the quarter before).SEC Form 13F
• H-1B filings certified in Q2 2026: 40 (7 a year earlier).U.S. Department of Labor (OFLC)

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for Elanco yet.

1 action in the last 12 months · 0 workers in WARN notices · latest Dec 9, 2025

1. Dec 9, 2025SEC filing
   8-K Item 2.05 (exit or disposal costs)
2. Feb 26, 2024SEC filing
   8-K Item 2.05 (exit or disposal costs)
3. Nov 30, 2021SEC filing
   8-K Item 2.05 (exit or disposal costs)
4. Jan 26, 2021SEC filing
   8-K Item 2.05 (exit or disposal costs)
5. Sep 30, 2020SEC filing
   8-K Item 2.05 (exit or disposal costs)
6. Sep 30, 2019SEC filing
   8-K Item 2.05 (exit or disposal costs)
7. Dec 14, 2018SEC filing
   8-K Item 2.05 (exit or disposal costs)

WARN notices cover layoffs above the federal size thresholds in the states Palanor reads; they are not every layoff. A WARN notice filed near an 8-K Item 2.05 of Elanco is linked to it and counted once. Methodology and coverage

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

1. Oct 20, 2026Lobbying
   Lobbying report (STUMPTOWN STRATEGIES)third_quarter 2026 · $0.0 million
2. Oct 20, 2026Lobbying
   Lobbying report (BOSE PUBLIC AFFAIRS GROUP)third_quarter 2026
3. Oct 20, 2026Lobbying
   Lobbying report (ELANCO ANIMAL HEALTH INCORPORATED)third_quarter 2026 · $0.2 million
4. Oct 20, 2026Patent
   Patent granted: FEED ADDITIVE COMPOSITIONSUS 12765577
5. Oct 19, 2026Lobbying
   Lobbying report (BROWNSTEIN HYATT FARBER SCHRECK, LLP)third_quarter 2026 · $0.1 million
6. Oct 13, 2026Lobbying
   Lobbying report (ANZU STRATEGIES)third_quarter 2026 · $0.0 million
7. Aug 25, 2026Patent
   Patent granted: JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTIONUS 12714674
8. Aug 11, 2026Patent
   Patent granted: NGF Antagonists for Medical UseUS 12703753
9. Aug 5, 2026Lobbying
   Lobbying report (STUMPTOWN STRATEGIES)third_quarter 2026
10. Jul 28, 2026Patent
    Patent granted: LYOPHILIZED CAKE IN STRAIGHT-WALLED VIALUS 12691033
11. Jul 20, 2026Lobbying
    Lobbying report (BOSE PUBLIC AFFAIRS GROUP)second_quarter 2026
12. Jul 20, 2026Lobbying
    Lobbying report (ELANCO ANIMAL HEALTH INCORPORATED)second_quarter 2026 · $0.2 million
13. Jul 14, 2026Patent
    Patent granted: METHODS AND FORMULATIONS FOR REDUCING BOVINE EMISSIONSUS 12677847
14. Jun 30, 2026Private credit
    Loans held by business development companies (Elanco Animal Health, Inc.)$3.8 million at cost
15. May 27, 20268-K
    Shareholder vote resultsItem 5.07
16. Feb 24, 202610-K
    Annual report (10-K)0 risk factors added, 0 removed
17. Dec 9, 20258-K
    Exit or restructuring costsItem 2.05
18. Nov 3, 20258-K
    Material agreement signedItem 1.01
19. Jun 26, 20258-K
    Material agreement signedItem 1.01
20. May 28, 20258-K
    Director or officer changeItem 5.02
21. May 21, 20258-K
    Shareholder vote resultsItem 5.07
22. Mar 17, 20258-K
    Director or officer changeItem 5.02
23. Feb 25, 202510-K
    Annual report (10-K)1 risk factors added, 1 removed
24. Nov 12, 20248-K
    Director or officer changeItem 5.02
25. Feb 26, 202410-K
    Annual report (10-K)3 risk factors added, 5 removed

Peers

Companies in the same sector in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

Identity

SEC CIK

1739104

LEI

549300SHPNDCE059M934

Wikidata

Q30280160